Interest
Interventional Cardiology

Qualifications
MBBS, University of Queensland, Australia, December 1983
MRCP (UK), September 1988

Consultant Pediatric Cardiologist
Glenmark Cardiac Centre
Nanavati Hospital, Mumbai
Breach Candy Hospital, Mumbai

Dr. Xavier Freixa is an Interventional Cardiologist at the Hospital Clinic of Barcelona, University of Barcelona. Dr. Freixa has been trained in interventional cardiology at the Toronto General Hospital, University Health Network and the Montreal Heart Institute, University of Montreal. He has a major interest in complex percutaneous coronary interventions, structural heart and adult congenital diseases. Among the main areas of interest highlight some advanced percutaneous techniques like PVL repair, left atrial appendage occlusion, ASD/VSD occlusion, TAVI and mitral valve repair with the Mitra-Clip system.

Prof. Hara is the Associate Professor at the Division of Cardiovascular Medicine, Toho University Ohashi Medical Center. He is specialize in doing PCI, EVT, and SHD intervention such as ASD/PFO/PVL closure, PTMC and BAV etc. Proctor for Occlutech PLD device, one of operators for Watchman Japan trial. He is also the Pesident of Structure Club Japan.

Dr. Hijazi is an interventional cardiologist who specializes in treating congenital & structural heart disease in both children and adults. He is a pioneer in the non-surgical repair of congenital and structural heart defects. His major area of interest is in the development of techniques and catheters/devices to help treat or cure congenital and structural cardiac disease without open-heart surgery.

Interventional Cardiologist at Montreal Heart Institute (Montreal, Canada) since 2002
Medical Director, Structural Heart Program since 2014
Associate Professor at University of Montreal since 2010
Accomplishment of many novelties including First-in-Man (FIM): Amplatzer Membranous Ventricular Septal Occluder II, Amplatzer Cardiac Plug (ACP) for left atrial appendage occlusion (LAAO)
Proctor in structural interventions (transcatheter aortic valve replacement (TAVR), left atrial appendage occlusion (LAAO), complex congenital procedures)
Clinical research in structural interventions (patent foramen ovale, left atrial appendage occlusion, congenital procedures, transcatheter aortic valve replacement) and atherosclerosis (progression-regression)
Member of the Left Atrial Appendage Academic Research Consortium (LAAARC) and of the Paravalvar Leak Consortium (PVLARC)

Consultant, Pediatric Heart Center, Queen Sirikit National Institute of Child Health (QSNICH), Bangkok, THAILAND
Board Committee, Society of Pediatric Cardiology of Thailand (SPCT)
Board Committee, Thai Resuscitation Council (TRC)
He has been working as a consultant of Pediatric Cardiology at QSNICH since 2006 mainly focusing on CHD and SHD Catheter Intervention. His clinical research interests are transcatheter therapy in various congenital heart lesions including the new system for percuteneous pulmonary valve implantation (PPVI) and long-term outcome of ASD device closure.

Trained in cardiology with special interest in congenital and structural heart diseases. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions. Has performed >1,000 TAVI procedures. PI for the NOTION I and NOTION II trial investigating TAVI vs. SAVR in younger, lower risk patients. Lead the first-in-human transcatheter mitral valve implantation in 2012.

Dr Apostolos Tzikas is an interventional cardiologist specialized in structural and congenital heart disease. He works at AHEPA University Hospital of Thessaloniki, Greece. He has a PhD from the Thoraxcenter, Rotterdam (supervised by Patrick W. Serruys) entitled "The role of advanced imaging in TAVI". He is an experienced clinical proctor for St Jude Medical in TAVI and LAA closure and he is responsible for the Amplatzer Cardiac Plug Registry, which has collected data on >1000 patient treated with in 22 centers worldwide.

Prof. Yin is the Chief of the Division of Cardiology at the Cheng-Hsin General Hospital in Taipei and Associate Professor of Internal Medicine at the National Yang-Ming University, School of Medicine, Taipei, Taiwan. He is also the current Secretary General of the Taiwan Society of Cardiology, Councilor of the Asian Pacific Society of Cardiology, and the former President of the Taiwan Society of Lipids and Atherosclerosis.

His interests include interventional cardiology, management of patients with high risk for cardiovascular disease, and heart failures research. Prof. Yin has participated in many international clinical trials such as HOKUSAI-VTE (national PI), ROCKET-AF, ASEND-HF, etc.,